Ignet

Gene Information

Gene symbol: PSG1

Gene name: pregnancy specific beta-1-glycoprotein 1

HGNC ID: 9514

Synonyms: PSGGA, CD66f, PBG1

Related Genes

#	Gene Symbol	Number of hits
1	AFP	1 hits
2	ALPP	1 hits
3	CGA	1 hits
4	CGB	1 hits
5	CGB5	1 hits
6	CSH1	1 hits
7	CTSG	1 hits
8	EPHA1	1 hits
9	INS	1 hits
10	PRL	1 hits
11	PSG5	1 hits

Related Sentences

#	PMID	Sentence
1	393298	Circulating levels of SP1 were measured in 20 insulin dependent diabetic women during the third trimester of pregnancy.
2	422088	[Pregnancy-specific beta-1-glycoprotein (SP-1) during the second half of pregnancy].
3	422088	By evaluation of maternal serum concentrations of SP-1 in cases of high-risk pregnancies with EPH-gestosis and fetal retardation relevant results could be demonstrated.
4	422088	[Pregnancy-specific beta-1-glycoprotein (SP-1) during the second half of pregnancy].
5	422088	By evaluation of maternal serum concentrations of SP-1 in cases of high-risk pregnancies with EPH-gestosis and fetal retardation relevant results could be demonstrated.
6	1280539	Amniotic fluid (AF) and maternal serum (MS) chorionic gonadotropin (HCG), placental lactogen (HPL), pregnancy-specific beta 1-glycoprotein (SP1), total estrogens (ET), alpha-fetoprotein (AFP) and prolactin (PRL) were measured by enzyme-immunoassays, in 50 normal (A) and in 37 abnormal (B) pregnancies, from 16th to 40th weeks.
7	1280539	A: the proteins HCG, AFP and PRL showed a similar decreasing trend after the 20th week, while HPL and SP1 rose progressively throughout the 2nd trimester, thereafter remaining constant.
8	1280539	Chorionic gonadotropin HPL and SP1 in MS were higher than in AF, while AF values of AFP and PRL were higher than in MS, but the ratio MS/AF of all hormone values increased significantly from the 2nd to the 3rd trimester (p < 0.005-p < 0.000001).
9	1280539	In erythroblastosis and diabetes, AFP was very low, but placental hormones, PRL and ET were both high and low.
10	1280539	In toxemia, SP1, hCG and PRL were elevated, while HPL and ET were very low.
11	1280539	Amniotic fluid (AF) and maternal serum (MS) chorionic gonadotropin (HCG), placental lactogen (HPL), pregnancy-specific beta 1-glycoprotein (SP1), total estrogens (ET), alpha-fetoprotein (AFP) and prolactin (PRL) were measured by enzyme-immunoassays, in 50 normal (A) and in 37 abnormal (B) pregnancies, from 16th to 40th weeks.
12	1280539	A: the proteins HCG, AFP and PRL showed a similar decreasing trend after the 20th week, while HPL and SP1 rose progressively throughout the 2nd trimester, thereafter remaining constant.
13	1280539	Chorionic gonadotropin HPL and SP1 in MS were higher than in AF, while AF values of AFP and PRL were higher than in MS, but the ratio MS/AF of all hormone values increased significantly from the 2nd to the 3rd trimester (p < 0.005-p < 0.000001).
14	1280539	In erythroblastosis and diabetes, AFP was very low, but placental hormones, PRL and ET were both high and low.
15	1280539	In toxemia, SP1, hCG and PRL were elevated, while HPL and ET were very low.
16	1280539	Amniotic fluid (AF) and maternal serum (MS) chorionic gonadotropin (HCG), placental lactogen (HPL), pregnancy-specific beta 1-glycoprotein (SP1), total estrogens (ET), alpha-fetoprotein (AFP) and prolactin (PRL) were measured by enzyme-immunoassays, in 50 normal (A) and in 37 abnormal (B) pregnancies, from 16th to 40th weeks.
17	1280539	A: the proteins HCG, AFP and PRL showed a similar decreasing trend after the 20th week, while HPL and SP1 rose progressively throughout the 2nd trimester, thereafter remaining constant.
18	1280539	Chorionic gonadotropin HPL and SP1 in MS were higher than in AF, while AF values of AFP and PRL were higher than in MS, but the ratio MS/AF of all hormone values increased significantly from the 2nd to the 3rd trimester (p < 0.005-p < 0.000001).
19	1280539	In erythroblastosis and diabetes, AFP was very low, but placental hormones, PRL and ET were both high and low.
20	1280539	In toxemia, SP1, hCG and PRL were elevated, while HPL and ET were very low.
21	1280539	Amniotic fluid (AF) and maternal serum (MS) chorionic gonadotropin (HCG), placental lactogen (HPL), pregnancy-specific beta 1-glycoprotein (SP1), total estrogens (ET), alpha-fetoprotein (AFP) and prolactin (PRL) were measured by enzyme-immunoassays, in 50 normal (A) and in 37 abnormal (B) pregnancies, from 16th to 40th weeks.
22	1280539	A: the proteins HCG, AFP and PRL showed a similar decreasing trend after the 20th week, while HPL and SP1 rose progressively throughout the 2nd trimester, thereafter remaining constant.
23	1280539	Chorionic gonadotropin HPL and SP1 in MS were higher than in AF, while AF values of AFP and PRL were higher than in MS, but the ratio MS/AF of all hormone values increased significantly from the 2nd to the 3rd trimester (p < 0.005-p < 0.000001).
24	1280539	In erythroblastosis and diabetes, AFP was very low, but placental hormones, PRL and ET were both high and low.
25	1280539	In toxemia, SP1, hCG and PRL were elevated, while HPL and ET were very low.
26	2481301	We correlated the villous histology with the immunocytochemical distribution of four trophoblastic proteins: beta human chorionic gonadotropin (beta HCG), placental alkaline phosphatase (PLAP), pregnancy specific beta-1-glycoprotein (SP1), and human placental lactogen (HPL) in 14 third-trimester placentas associated with diabetes mellitus.
27	2481301	Staining was increased for beta HCG and decreased for PLAP, SP1, and HPL in the diabetic placentas compared to control placentas of similar gestational age.
28	2481301	We correlated the villous histology with the immunocytochemical distribution of four trophoblastic proteins: beta human chorionic gonadotropin (beta HCG), placental alkaline phosphatase (PLAP), pregnancy specific beta-1-glycoprotein (SP1), and human placental lactogen (HPL) in 14 third-trimester placentas associated with diabetes mellitus.
29	2481301	Staining was increased for beta HCG and decreased for PLAP, SP1, and HPL in the diabetic placentas compared to control placentas of similar gestational age.
30	6416936	Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) in women with pregnancies at risk.
31	6416936	Pregnancy-specific beta 1-glycoprotein (SP1) concentrations were measured by nephelometry in 133 serum samples from 74 women in their last trimester of pregnancy.
32	6416936	Women with insulin-dependent diabetes mellitus who gave birth to infants to normal birth weight or large-for-date infants had SP1 levels well within the reference range and even showed a tendency to overrepresentation above the geometric mean.
33	6416936	Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) in women with pregnancies at risk.
34	6416936	Pregnancy-specific beta 1-glycoprotein (SP1) concentrations were measured by nephelometry in 133 serum samples from 74 women in their last trimester of pregnancy.
35	6416936	Women with insulin-dependent diabetes mellitus who gave birth to infants to normal birth weight or large-for-date infants had SP1 levels well within the reference range and even showed a tendency to overrepresentation above the geometric mean.
36	6416936	Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) in women with pregnancies at risk.
37	6416936	Pregnancy-specific beta 1-glycoprotein (SP1) concentrations were measured by nephelometry in 133 serum samples from 74 women in their last trimester of pregnancy.
38	6416936	Women with insulin-dependent diabetes mellitus who gave birth to infants to normal birth weight or large-for-date infants had SP1 levels well within the reference range and even showed a tendency to overrepresentation above the geometric mean.
39	6787188	Sp1, the pregnancy-specific beta 1-glycoprotein, was studied in normal and pathologic pregnancies.
40	6787188	Since the radioimmunological determination of SP1 is possible in the early stage of gestation (from week 8) it may serve as a useful tool for prediction at times when the determination of placental lactogen is not yet possible.
41	6787188	Serial determinations of SP1 in the serum of women with EPH-gestosis were compared with the corresponding HPL determinations and showed the equality of SP1 concerning the assessment of the placental function.
42	6787188	Sp1, the pregnancy-specific beta 1-glycoprotein, was studied in normal and pathologic pregnancies.
43	6787188	Since the radioimmunological determination of SP1 is possible in the early stage of gestation (from week 8) it may serve as a useful tool for prediction at times when the determination of placental lactogen is not yet possible.
44	6787188	Serial determinations of SP1 in the serum of women with EPH-gestosis were compared with the corresponding HPL determinations and showed the equality of SP1 concerning the assessment of the placental function.
45	6787188	Sp1, the pregnancy-specific beta 1-glycoprotein, was studied in normal and pathologic pregnancies.
46	6787188	Since the radioimmunological determination of SP1 is possible in the early stage of gestation (from week 8) it may serve as a useful tool for prediction at times when the determination of placental lactogen is not yet possible.
47	6787188	Serial determinations of SP1 in the serum of women with EPH-gestosis were compared with the corresponding HPL determinations and showed the equality of SP1 concerning the assessment of the placental function.
48	7527583	They were examined for alpha-1-fetoprotein (MS AFP) and trophoblast-specific beta-1-glycoprotein (MS SP1): in chosen cases chorionic gonadotropine (MS HCG) was assessed at the same time.
49	7527583	The second group were 35 insulin-dependent pregnant diabetics followed-up in Regional Ambulance of Central Bohemia and hospitalized at the First Clinic of Obstetrics and Gynaecology of the First Medical Faculty, whose MS SP1 levels were being assessed (usually in one-week intervals) during the second and third trimester of pregnancy. 21 patients were simultaneously examined for glycated serum proteins.
50	7527583	They were examined for alpha-1-fetoprotein (MS AFP) and trophoblast-specific beta-1-glycoprotein (MS SP1): in chosen cases chorionic gonadotropine (MS HCG) was assessed at the same time.
51	7527583	The second group were 35 insulin-dependent pregnant diabetics followed-up in Regional Ambulance of Central Bohemia and hospitalized at the First Clinic of Obstetrics and Gynaecology of the First Medical Faculty, whose MS SP1 levels were being assessed (usually in one-week intervals) during the second and third trimester of pregnancy. 21 patients were simultaneously examined for glycated serum proteins.